Silgan CFO gets 20,500 restricted stock units

Silgan Holdings EVP & Chief Financial Officer Shawn C. Fabry reported two equity-related transactions in Silgan common stock.

Rhea-AI Filing Summary

Silgan Holdings EVP & Chief Financial Officer Shawn C. Fabry reported two equity-related transactions in Silgan common stock. On March 1, 2026, he had 2,064 shares disposed of at $47.57 per share to cover tax obligations.

On the same date, he received a grant of 20,500 restricted stock units (RSUs) at no cost under Silgan’s Second Amended and Restated 2004 Stock Incentive Plan. These RSUs vest in equal portions over five years starting March 1, 2027 and settle 1-for-1 in common shares upon vesting. Following these transactions, his directly held and RSU-based interest totaled 95,949 shares, including 62,520 unvested RSUs granted under Silgan equity plans.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider FABRY SHAWN C

Role EVP & Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	2,064	$47.57	$98K
Grant/Award	Common Stock	20,500	$0.00	$0.00

Holdings After Transaction: Common Stock — 95,949 shares (Direct)

Footnotes (2)

1. F1. These securities are restricted stock units that were granted on March 1, 2026 under the Silgan Holdings Inc. Second Amended and Restated 2004 Stock Incentive Plan. These restricted stock units vest ratably over a 5 year period beginning on March 1, 2027 and will be settled in shares of Common Stock on a 1-for-1 basis upon vesting.
2. F2. This amount includes 62,520 restricted stock units that are not yet vested that have been granted under equity compensation plans of Silgan Holdings Inc. Upon vesting, these restricted stock units will be settled in shares of Common Stock on a 1-for-1 basis.

FAQ

What equity award did Silgan (SLGN) CFO Shawn C. Fabry receive?

Shawn C. Fabry received an award of 20,500 restricted stock units (RSUs) in Silgan common stock. The RSUs were granted under Silgan’s Second Amended and Restated 2004 Stock Incentive Plan at $0 cost and will settle 1-for-1 in shares when they vest.

How do the new RSUs granted to Silgan (SLGN) CFO vest over time?

The 20,500 RSUs granted to the Silgan CFO vest ratably over five years beginning on March 1, 2027. Each year, a portion vests and converts into Silgan common stock on a 1-for-1 basis, aligning compensation with longer-term company performance.

Why were 2,064 Silgan (SLGN) shares disposed of by the CFO?

The 2,064 Silgan common shares were disposed of at $47.57 per share in a tax-withholding transaction. This type of Form 4 code F transaction covers tax liabilities associated with equity awards rather than representing an open-market sale decision by the executive.

What is Shawn C. Fabry’s total reported Silgan (SLGN) share interest after these transactions?

After the reported transactions, Shawn C. Fabry’s total reported interest is 95,949 Silgan common shares. This figure includes 62,520 unvested restricted stock units granted under Silgan’s equity compensation plans, which will convert into shares on a 1-for-1 basis upon vesting.

How many unvested RSUs does the Silgan (SLGN) CFO now hold?

The Silgan CFO’s holdings include 62,520 unvested restricted stock units (RSUs) granted under the company’s equity compensation plans. These RSUs are scheduled to be settled in Silgan common stock on a 1-for-1 basis as they vest over their respective vesting schedules.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 04:34 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FABRY SHAWN C

(Last) (First) (Middle)

C/O SILGAN HOLDINGS INC

601 MERRITT 7, FLOOR 1

(Street)

NORWALK CT 06851

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SILGAN HOLDINGS INC [ SLGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/01/2026		F		2,064	D	$47.57	75,449	D
Common Stock	03/01/2026		A		20,500	A	(1)	95,949(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These securities are restricted stock units that were granted on March 1, 2026 under the Silgan Holdings Inc. Second Amended and Restated 2004 Stock Incentive Plan. These restricted stock units vest ratably over a 5 year period beginning on March 1, 2027 and will be settled in shares of Common Stock on a 1-for-1 basis upon vesting.

2. This amount includes 62,520 restricted stock units that are not yet vested that have been granted under equity compensation plans of Silgan Holdings Inc. Upon vesting, these restricted stock units will be settled in shares of Common Stock on a 1-for-1 basis.

Remarks:

	/s/ Frank W. Hogan, III, Attorney-in-fact for Shawn C. Fabry	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.